Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults

Last updated: October 14, 2024
Sponsor: Federal University of Uberlandia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sarcopenia

Treatment

Whey Protein + Placebo

Placebo Group

Omega 3 + Whey Protein

Clinical Study ID

NCT05862779
5.728.049
  • Ages 60-85
  • Female
  • Accepts Healthy Volunteers

Study Summary

To evaluate the effect of omega-3 supplementation combined with whey protein intake on lean mass and strength gains in older adults performing resistance exercise. Participants will be randomized into the 4 groups. The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin. The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin. The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil. The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein. All will perform the same exercise protocol for 12 weeks

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Postmenopausal women (at least 1 year of menstrual interruption, self-reported);

  • To be able to practice strength exercises;

  • To be able to carry out supplementation;

  • Do not present physical, orthopedic or cardiovascular complications that prevent theperformance of physical exercises;

  • No history of stroke or acute myocardial infarction;

  • Not being a smoker and/or alcoholic;

  • Do not perform hormone replacement therapy;

  • Do not use anti-inflammatory drugs;

  • To have normal kidney function;

  • To submit a medical certificate of health that proves that the individual is able toperform exercises.

Exclusion

Exclusion Criteria:

  • Do not provide the necessary information for the development of the study;

  • Individuals with diseases previously diagnosed and undergoing treatment, such astype II diabetes mellitus, cancer, rheumatoid arthritis, high blood pressure,dyslipidemia, cardiovascular, and kidney and/or liver diseases.

Study Design

Total Participants: 80
Treatment Group(s): 4
Primary Treatment: Whey Protein + Placebo
Phase:
Study Start date:
July 30, 2024
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • Federal University of Uberlandia

    Uberlandia, Minas Gerais 38400-902
    Brazil

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.